The cell growth assay showed that overexpression of EYA2 enhanced lung cancer cell growth, while re-expression of PTEN significantly compromised the growth advantage conferred by EYA2 in A549 cells (*p < 0.05, Figure 4A). This evidence concerns the gene EYA2 and lung cancer.